![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 28, 26227-26237, July 11, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||







From the
Departments of
Medicine D,
Albert-Schweitzer-Str. 33, **Physiological Chemistry
and Pathobiochemistry, Waldeyerstr. 15, and

Dermatology, Von-Esmarchstr. 58,
University of Münster, 48149 Münster, Germany,
¶Pharmazentrum Frankfurt, University of
Frankfurt, Theodor-Stern-Kai 7, 60590 Frankfurt/Main, Germany, and
||Institute of Molecular Biology, Slovak Academy of
Sciences, Dubravska cesta 21, 84251 Bratislava, Slovak Republic
During glomerular inflammation mesangial cells are the major source and
target of nitric oxide that pro-foundly influences proliferation, adhesion,
and death of mesangial cells. The effect of nitric oxide on the mRNA
expression pattern of cultured rat mesangial cells was therefore investigated
by RNA-arbitrarily-primed polymerase chain reaction. Employing this approach,
biglycan expression turned out to be down-regulated time- and dose-dependently
either by interleukin-1
-stimulated endogenous nitric oxide production or
by direct application of the exogenous nitric oxide donor, diethylenetriamine
nitric oxide. There was a corresponding decline in the rate of biglycan
biosynthesis and in the steady state level of this proteoglycan. In
vivo, in a model of mesangioproliferative glomerulonephritis
up-regulation of inducible nitric-oxide synthase mRNA was associated with
reduced expression of biglycan in isolated glomeruli. Biglycan expression
could be normalized, both in vitro and in vivo, by using a
specific inhibitor of the inducible nitric-oxide synthase,
l-N6-(l-iminoethyl)-l-lysine dihydrochloride. Further
studies showed that biglycan inhibited cell adhesion on type I collagen and
fibronectin because of its binding to these substrates. More importantly,
biglycan protected mesangial cells from apoptosis by decreasing caspase-3
activity, and it counteracted the proliferative effects of platelet-derived
growth factor-BB. These findings indicate a signaling role of biglycan and
describe a novel pathomechanism by which nitric oxide modulates the course of
renal glomerular disease through regulation of biglycan expression.
Received for publication, October 16, 2002 , and in revised form, March 24, 2003.
* This work was supported by the Deutsche Forschungsgemeinschaft (SFB 492, project B10 and SFB 553, projects SCHA 970/11 and PF 361/11) and the Interdisciplinary Centre for Clinical Research, University of Münster (Project D18). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Medizinische Klinik und Poliklinik
D, Albert-Schweitzer-Str. 33, 48149 Münster, Germany. Tel.:
49-251-834-7525; Fax: 49-251-834-9547; E-mail:
schaefl{at}unimuenster.de.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. L. D'Antoni, C. Torregiani, P. Ferraro, M.-C. Michoud, B. Mazer, J. G. Martin, and M. S. Ludwig Effects of decorin and biglycan on human airway smooth muscle cell proliferation and apoptosis Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L764 - L771. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Westermann, J. Mersmann, A. Melchior, T. Freudenberger, C. Petrik, L. Schaefer, R. Lullmann-Rauch, O. Lettau, C. Jacoby, J. Schrader, et al. Biglycan Is Required for Adaptive Remodeling After Myocardial Infarction Circulation, March 11, 2008; 117(10): 1269 - 1276. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schaefer, W. Tsalastra, A. Babelova, M. Baliova, J. Minnerup, L. Sorokin, H.-J. Grone, D. P. Reinhardt, J. Pfeilschifter, R. V. Iozzo, et al. Decorin-Mediated Regulation of Fibrillin-1 in the Kidney Involves the Insulin-Like Growth Factor-I Receptor and Mammalian Target of Rapamycin Am. J. Pathol., January 1, 2007; 170(1): 301 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-F. Beck, G. Guder, L. Schaefer, M. Pleskova, A. Babelova, M. H. Behrens, D. Mihalik, M. Beck, R. M. Schaefer, and J. Pfeilschifter Nitric Oxide Upregulates Induction of PDGF Receptor-{alpha} Expression in Rat Renal Mesangial Cells and in Anti-Thy-1 Glomerulonephritis J. Am. Soc. Nephrol., July 1, 2005; 16(7): 1948 - 1957. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-Q. Qiu, R. Sinniah, and S. I-H. Hsu Coupled Induction of iNOS and p53 Upregulation in Renal Resident Cells May Be Linked with Apoptotic Activity in the Pathogenesis of Progressive IgA Nephropathy J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2066 - 2078. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schaefer, D. Mihalik, A. Babelova, M. Krzyzankova, H.-J. Grone, R. V. Iozzo, M. F. Young, D. G. Seidler, G. Lin, D. P. Reinhardt, et al. Regulation of Fibrillin-1 by Biglycan and Decorin Is Important for Tissue Preservation in the Kidney During Pressure-Induced Injury Am. J. Pathol., August 1, 2004; 165(2): 383 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shimizu-Hirota, H. Sasamura, M. Kuroda, E. Kobayashi, M. Hayashi, and T. Saruta Extracellular Matrix Glycoprotein Biglycan Enhances Vascular Smooth Muscle Cell Proliferation and Migration Circ. Res., April 30, 2004; 94(8): 1067 - 1074. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |